Industry Experts - Market Research Reports, Industry Analysis, Custom Research

Industry Experts, Inc. published the new market research report " Global Atrial Fibrillation Market – Treatment Types and End-User Facilities ". As per the new report, Non-Pharmacological Treatment is estimated the largest type for Atrial Fibrillation treatment accounting for about 59% market in 2021 while the same is projected to grow by the fastest CAGR of 13.6% during the period 2022-2027. Atrial Fibrillation (AF) is the most common arrhythmia, which can lead to stroke, peripheral embolization, heart failure and other unfavorable outcomes. While the incidence of AF among the general population has been found to be at about 2.3%-3.4%, this registers a significant increase in patients with pulmonary disease, critical illness or systemic inflammatory response syndrome, with devastating clinical impact. A number of recent epidemiological studies have established a greater risk of AF and new-onset AF among patients with COVID-19, though the results have been quite inconsistent